Jin Yan

2.7k total citations · 1 hit paper
87 papers, 2.1k citations indexed

About

Jin Yan is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Jin Yan has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 28 papers in Oncology and 15 papers in Biomedical Engineering. Recurrent topics in Jin Yan's work include Nanoplatforms for cancer theranostics (13 papers), Advanced biosensing and bioanalysis techniques (13 papers) and RNA Interference and Gene Delivery (11 papers). Jin Yan is often cited by papers focused on Nanoplatforms for cancer theranostics (13 papers), Advanced biosensing and bioanalysis techniques (13 papers) and RNA Interference and Gene Delivery (11 papers). Jin Yan collaborates with scholars based in China, United States and Nigeria. Jin Yan's co-authors include Wangxiao He, Wuyuan Lu, Siqi Yan, X. Peter, Weiming You, Bo Lei, Wenguang Yang, Yu Yao, Peng Hou and Yongping Shao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jin Yan

82 papers receiving 2.1k citations

Hit Papers

Small-molecule-induced li... 2025 2026 2025 5 10 15

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jin Yan 1.1k 620 494 444 294 87 2.1k
Wangxiao He 920 0.9× 570 0.9× 457 0.9× 393 0.9× 295 1.0× 72 1.9k
Jooho Park 920 0.9× 760 1.2× 404 0.8× 622 1.4× 188 0.6× 73 2.1k
Ran Tian 1.0k 0.9× 460 0.7× 320 0.6× 384 0.9× 151 0.5× 40 1.9k
Yojiro Maehata 748 0.7× 454 0.7× 371 0.8× 339 0.8× 209 0.7× 32 1.9k
Takemi Tanaka 1.2k 1.1× 751 1.2× 329 0.7× 692 1.6× 405 1.4× 62 2.5k
Mohammad Amini 1.0k 1.0× 812 1.3× 281 0.6× 513 1.2× 352 1.2× 86 2.2k
Houría Boulaiz 928 0.9× 406 0.7× 332 0.7× 383 0.9× 220 0.7× 84 2.0k
Min Han 1.4k 1.4× 906 1.5× 426 0.9× 1.0k 2.3× 284 1.0× 103 3.1k
Hanqing Qian 689 0.7× 725 1.2× 254 0.5× 752 1.7× 249 0.8× 58 1.8k
Lei Yu 1.1k 1.1× 663 1.1× 982 2.0× 495 1.1× 163 0.6× 104 2.7k

Countries citing papers authored by Jin Yan

Since Specialization
Citations

This map shows the geographic impact of Jin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Yan more than expected).

Fields of papers citing papers by Jin Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Yan. The network helps show where Jin Yan may publish in the future.

Co-authorship network of co-authors of Jin Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Yan. A scholar is included among the top collaborators of Jin Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Yan. Jin Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Wei, et al.. (2025). Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with Metformin. International Journal of Molecular Sciences. 26(22). 11061–11061.
2.
Liao, Chongbing, Jin Yan, William D. Tolbert, et al.. (2025). A Dual-Specificity d-Peptide Antagonist of MDM2 and MDMX for Antitumor Immunotherapy. Journal of Medicinal Chemistry. 68(16). 16940–16957.
3.
You, Weiming, Xiaoqiang Zheng, Jin Yan, et al.. (2025). Dual-targeted N-PMIplus@CA nanoplatform for concurrent MDM2 and β-catenin inhibition in p53 wild-type lung adenocarcinoma. Materials Today Bio. 34. 102136–102136. 1 indexed citations
4.
Qin, Zuodong, Jin Yan, Leyong Wang, et al.. (2025). Polydopamine Microspheres Loaded with Antimicrobial Peptide HX-12C Pullulan/Gelatin Hydrogel for Burn Wound Healing. ACS Applied Polymer Materials. 7(15). 9517–9530. 1 indexed citations
5.
Liu, Na, Xiaoqiang Zheng, Jin Yan, et al.. (2024). Reversing MET‐Mediated Resistance in Oncogene‐Driven NSCLC by MET‐Activated Wnt Condensative Prodrug. Advanced Science. 11(30). e2400603–e2400603. 5 indexed citations
7.
Zhang, Lin, et al.. (2024). Entropy-based geometric measures of correlations for bell diagonal states via measurement. Physica Scripta. 99(12). 125102–125102.
8.
Yan, Siqi, Wenguang Yang, Weiming You, et al.. (2024). Resurrecting p53 by an Artificial Nano‐Protein for Potent Photodynamic Retinoblastoma Therapy. Small. 21(4). e2401260–e2401260. 1 indexed citations
9.
He, Wangxiao, Yang Wang, Xiao Li, et al.. (2024). Sealing the Pandora’s vase of pancreatic fistula through entrapping the digestive enzymes within a dextrorotary (D)-peptide hydrogel. Nature Communications. 15(1). 7235–7235. 28 indexed citations
10.
Yan, Jin, Yue Shu, Tian Qin, et al.. (2023). Asperosaponin VI protects alcohol-induced hepatic steatosis and injury via regulating lipid metabolism and ER stress. Phytomedicine. 121. 155080–155080. 14 indexed citations
12.
Feng, Jiawen, Weiqi Zhang, Xuyang Zhao, et al.. (2019). PTEN arginine methylation by PRMT6 suppresses PI3K–AKT signaling and modulates pre-mRNA splicing. Proceedings of the National Academy of Sciences. 116(14). 6868–6877. 57 indexed citations
13.
Ma, Bohan, F. Niu, Xiaoyan Qu, et al.. (2019). A tetrameric protein scaffold as a nano-carrier of antitumor peptides for cancer therapy. Biomaterials. 204. 1–12. 35 indexed citations
14.
15.
Li, Yang, Yifei Li, Yuhui Zhu, et al.. (2016). CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells. Virus Research. 220. 172–178. 19 indexed citations
16.
Armstrong, Michaele J., et al.. (2015). IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition. Cancer Biology & Therapy. 16(7). 1029–1041. 27 indexed citations
17.
Liu, Guangyao, Zhijie Li, Qinglin Li, et al.. (2015). Enhanced growth suppression of TERT-positive tumor cells by oncolytic adenovirus armed with CCL20 and CD40L. International Immunopharmacology. 28(1). 487–493. 15 indexed citations
18.
Yan, Jin, Wangxiao He, Na Li, et al.. (2015). Simultaneously targeted imaging cytoplasm and nucleus in living cell by biomolecules capped ultra-small GdOF nanocrystals. Biomaterials. 59. 21–29. 26 indexed citations
19.
Wang, Yujun, Ernest Han, Jin Yan, et al.. (2014). Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells. Cancer Letters. 358(2). 170–179. 75 indexed citations
20.
Gao, Jinbo, Yujun Wang, Jin Yan, et al.. (2011). Identification of a Natural Compound by Cell-Based Screening That Enhances Interferon Regulatory Factor-1 Activity and Causes Tumor Suppression. Molecular Cancer Therapeutics. 10(10). 1774–1783. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026